**Core Concept**
Cryoprecipitate is a blood product derived from plasma that is rich in fibrinogen, factor VIII, factor XIII, and von Willebrand factor. It is used to replace these clotting factors in patients with bleeding disorders or those requiring surgical interventions.

**Why the Correct Answer is Right**
Cryoprecipitate is particularly useful in patients with hypofibrinogenemia, which can occur due to liver disease, disseminated intravascular coagulation (DIC), or massive transfusion. The fibrinogen content in cryoprecipitate helps to stabilize clots and prevent bleeding. Additionally, the presence of factor XIII in cryoprecipitate aids in the cross-linking of fibrin, further enhancing clot stability.

**Why Each Wrong Option is Incorrect**
**Option A:** Cryoprecipitate is not primarily used for replacing platelets, which are essential for primary hemostasis. Platelet transfusions are more appropriate for patients with thrombocytopenia.

**Option B:** While cryoprecipitate does contain factor VIII, it is not the preferred source for patients with hemophilia A. Factor VIII concentrates are more concentrated and purified, making them a better choice for these patients.

**Option C:** Cryoprecipitate does not contain significant amounts of albumin, which is essential for maintaining oncotic pressure. Albumin infusions are used to treat hypoolbuminemia, not cryoprecipitate.

**Clinical Pearl / High-Yield Fact**
Cryoprecipitate is often used in emergency situations where rapid fibrinogen replacement is required. However, it is essential to note that cryoprecipitate can contain viruses and other infectious agents, making it a high-risk product. As such, it should be used judiciously and only when other alternatives are not available.

**Correct Answer:** D.